These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15325699)

  • 1. Clinical staging and prognostic markers in chronic lymphocytic leukemia.
    Rai KR; Wasil T; Iqbal U; Driscoll N; Patel D; Janson D; Mehrotra B
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):795-805, vii. PubMed ID: 15325699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and clinical staging in chronic lymphocytic leukemia.
    Rai KR; Han T
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):447-56. PubMed ID: 2182601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic markers in chronic lymphocytic leukaemia.
    Hamblin TJ
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smudge cells, serum albumin, and prognosis in B-cell chronic lymphocytic leukemia.
    Go RS
    J Clin Oncol; 2009 Aug; 27(22):e44; author reply e45. PubMed ID: 19581530
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk stratification in chronic lymphocytic leukemia.
    Seiler T; Döhner H; Stilgenbauer S
    Semin Oncol; 2006 Apr; 33(2):186-94. PubMed ID: 16616065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.
    Rossi D; Zucchetto A; Rossi FM; Capello D; Cerri M; Deambrogi C; Cresta S; Rasi S; De Paoli L; Bodoni CL; Bulian P; Del Poeta G; Ladetto M; Gattei V; Gaidano G
    Haematologica; 2008 Oct; 93(10):1575-9. PubMed ID: 18641015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of prognostic factors in risk stratification at diagnosis and time of treatment of patients with chronic lymphocytic leukemia.
    Gowda A; Byrd JC
    Curr Opin Hematol; 2006 Jul; 13(4):266-72. PubMed ID: 16755224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the (A, B, C) staging and the Rai's staging from a large prospective series (935 patients). French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):363-7. PubMed ID: 3222146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in chronic lymphocytic leukemia.
    Hallek M; Kuhn-Hallek I; Emmerich B
    Leukemia; 1997 Apr; 11 Suppl 2():S4-13. PubMed ID: 9178831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in chronic lymphocytic leukaemia: contribution of recent biological markers].
    Evrard S; Gaussem P; Helley D; Darnige L
    Ann Biol Clin (Paris); 2005; 63(6):589-97. PubMed ID: 16330377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphoproliferative disorders.
    Montserrat E; Binet JL; Dighiero G; Gale RP; Juliusson G; Keating M; Rai KR
    Rev Invest Clin; 1994 Apr; Suppl():52-8. PubMed ID: 7886310
    [No Abstract]   [Full Text] [Related]  

  • 14. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA; Craig FE; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches to chronic lymphocytic leukemia.
    Robertson LE; Keating MJ
    Tex Med; 1991 Nov; 87(11):68-74. PubMed ID: 1759245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
    Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R
    Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More on early chronic lymphocytic leukemia (CLL): clinical staging systems and indications for treatment.
    Jaksic B; Kusec R
    Hematol Pathol; 1992; 6(4):219-21. PubMed ID: 1490994
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia.
    Ghia P; Ferreri AM; Caligaris-Cappio F
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):234-46. PubMed ID: 17544290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukaemia.
    Boelens J; Lust S; Vanhoecke B; Offner F
    Anticancer Res; 2009 Feb; 29(2):605-15. PubMed ID: 19331210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.